Good point! Management has taken huge risks in the past getting the company set up and deserve to be rewarded for their past and continued commitment.
I think today we should focus on the nice development that kevetrin has a new clinical site for trial enrollment at a very well respected and prestigious institution.
With a second site in place, small trial sample size, relatively short trial duration; this will hopefully expedite and provide proof of concept over next several months. Progress continues and therefore I remain increasingly hopeful for a bright future.
Thanks to those who have uncovered this recent development. That is the benefit of this message board and the main reason I am a participant.
Hi Sox, Probably because it would be a Big Red Flag for pending investors, and the PPS wouldn't have gone over $1.50
What Drugs ? You mean the compounds that they hope to turn into 'Drugs', but first they have to pass Phase 3 ( the most difficult and costly phase, with the highest failure rate), which they are not even close ? Those 'drugs' ?
The way the PPS is going, IPIX can't get more cash, due to senior existing Toxic Funding which is already running them down to the nub.
Only a Hail Mary connect will help Leo and the crew of the round table (BOD). As the stock continues falling into the .60's it's in serious danger of penetrating .63 PS.
With no up-list possible, and Leo won't RS, there are few other options 'down here'.